Aptar And Chiesi Sign Digital Health Contract To Bring Best-In-Class Disease Management Platform For Patients With Asthma And COPD
October 18, 8:39 AM
Aptar Digital Health and Chiesi will offer patients a comprehensive set of services and solutions Aptar Digital Health, part of Aptar Pharma, a global leader in drug delivery and active material science solutions and
August 4, 4:52 AM
Clinical stage drug developer Pharmaxis (ASX: PXS) today announced that Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, has exercised the option to acquire the worldwide rights to Pharmaxis' proprietary inhaler Orbital, a unique device designed to deliver high payload dry powder to the lungs.
July 21, 11:05 AM
Monday marks the last chance for investors to receive the next dividend payout from AptarGroup (NYSE:ATR).
July 18, 12:01 PM
Wells Fargo has decided to maintain its Overweight rating of AptarGroup (NYSE:ATR) and lower its price target from $150.00 to $125.00. Shares of AptarGroup are trading down 0.4% over the last 24 hours, at $99.61 per share. A move to $125.00 would account for a 25.49% increase from the current share price.